person

Marianne T. S.

Country
Denmark
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
88
Sites with multiple studies

Has run more than one trial at 88 of 283 partner sites.

Specializations

Hematologic Malignancies

This investigator specializes in treating various forms of blood cancers, with particular expertise in Acute Myeloid Leukemia (AML) and innovative combination therapies using targeted treatments.

  • Advanced AML Treatment Protocols
  • Combination Therapy Approaches
  • Novel Drug Applications

The research encompasses evaluation of treatment responses and survival outcomes in AML patients.

Myeloproliferative Disorders

Dedicated to advancing treatment options for patients with myelofibrosis and related conditions, including post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

  • Primary Myelofibrosis
  • Post-PV/ET Myelofibrosis
  • Long-term Disease Management

Focus on developing extended access programs and evaluating novel therapeutic agents for myeloproliferative disorders.

Rare Hematologic Conditions

Investigates innovative treatments for rare blood disorders, including VEXAS syndrome and Myelodysplastic Syndrome (MDS), with emphasis on targeted therapeutic approaches.

  • VEXAS Syndrome Treatment
  • Low/Intermediate Risk MDS
  • Molecular Response Assessment

Specializes in evaluating novel oral therapeutics and monitoring molecular markers for treatment response.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.